Diverse Biotech selected to present at upcoming BIO Meeting and announces new Gene Expression Paper Publication

Tuesday, February 11, 2020 Genetics & Stem Cells News
Email Print This Page Comment bookmark
Font : A-A+

DOYLESTOWN, Pa., Feb. 10, 2020 /PRNewswire/ -- Diverse Biotech, Inc. www.diversebiotech.com has announced it has been selected to present at the upcoming BIO CEO & Investor Conference in New York on February 11th.  https://www.bio.org/events/bio-ceo-investor-conference/sessions/659395

In addition, Diverse Biotech has announced that a paper regarding cannabinoid-related gene expression was accepted by the Journal of Applied Cell Biology. The paper should be published in the next 3-4 weeks.

"We are truly excited to continue to discuss our ground-breaking technology. In addition, the gene expression paper is tremendous because it highlights that a variety of cell lines including glioblastoma, pancreatic cancer, melanoma, actinic keratosis, squamous cell carcinoma, and normal skin – all express genes that suggest they will be responsive to exogenous cannabinoid treatment," said Stella Vnook, Diverse Biotech's Chief Executive Officer.

About Diverse Biotech

Diverse Biotech is a US-based biopharmaceutical company, focused on medical discoveries and the development of new molecules for the treatment of Cancer and other debilitating diseases. Our focus is on discovering and developing novel therapeutics utilizing cannabidiol (CBD) as a core component and combining it through highly advanced chemistry with other molecules to develop new chemical entities that are theoretically more efficacious and less toxic. Our initial focus is on hard-to-treat oncologic disorders including basal cell carcinoma and other Dermatology related cancers, Pancreatic cancer and Glioblastoma, where targeted therapies have proven largely unsuccessful thus far and there is significant unmet need.

Further information about Diverse Biotech can be found at www.diversebiotech.com.

Contacts:Brian LongstreetChief Business OfficerDiverse Biotech, Inc +1-908-917-5699blongstreet@diversebiotech.com

Cision View original content:http://www.prnewswire.com/news-releases/diverse-biotech-selected-to-present-at-upcoming-bio-meeting-and-announces-new-gene-expression-paper-publication-301002178.html

SOURCE Diverse Biotech, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store